The US FDA has approved Vyloy in combination with fluoropyrimidine- and platinum-containing chemotherapy for the first-line treatment of advanced gastric or gastroesophageal junction cancer.

The prevalence of HCV among men who have sex with men with non-injection drug use is linked to age and drug use patterns.

During August 2021 to August 2023, the prevalence of adult hypertension was 47.7 percent, with hypertension higher in men than women.

Gallstone disease is associated with the development of inflammatory bowel diseases, such as Crohn disease and ulcerative colitis.

Urban green spaces appear to play an important role in mitigating heat-related health risks, according to a review published online.

Patients with cystic fibrosis experience significant bone mineral density loss at a younger age than those without the disease.

Long-term exposure to inorganic arsenic in drinking water (wAs) from US community water supplies (CWS) at levels below the federal maximum contaminant level of 10 µg/L is associated with an increased ...

The Food and Drug Administration (FDA) has approved Imuldosa ™ (ustekinumab-srlf), a biosimilar to Stelara ® (ustekinumab), for the treatment of various chronic inflammatory diseases. Imuldosa, ...

Progression rates to gastric cancer are similar across countries with low or medium/high incidence. Low and medium/high gastric cancer (GC) incidence countries have similar progression rates for ...

Selarsdi (ustekinumab-aekn), a biosimilar to Stelara (ustekinumab), is expanded to the indications to include treatment of Crohn disease.

Endoscopic ultrasound-guided biliary drainage (EUS-BD) is shorter and reduces risk for postprocedural pancreatitis compared with endoscopic retrograde cholangiopancreatography (ERCP) for the ...

The number of pediatric psychology referrals for issues related to food allergy increased dramatically during the past decade.